Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber’s hereditary optic neuropathy patients
In Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could...
Saved in:
Published in | Frontiers in neuroscience Vol. 16; p. 917348 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
09.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could ameliorate mtDNA mutation mediated mitochondrial dysfunction in skin fibroblasts of LHON patients and explore the underlying mechanisms.BackgroundIn Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could ameliorate mtDNA mutation mediated mitochondrial dysfunction in skin fibroblasts of LHON patients and explore the underlying mechanisms.The skin of normal healthy subjects and severe LHON patients harboring m.11778G > A mutation was taken to prepare immortalized skin fibroblast cell lines (control-iFB and LHON-iFB). LHON-iFB cells were transfected with SOD2 plasmid or negative control plasmid, respectively. In addition, human neuroblastoma SH-SY5Y cells and human primary retinal pigmental epithelium (hRPE) cells were stimulated by H2O2 after gene transfection. The oxygen consumption rate (OCR) was measured with a Seahorse extracellular flux analyzer. The level of ATP production, mitochondrial membrane potential, ROS and malondialdehyde (MDA) were measured separately with the corresponding assay kits. The expression level of SOD2, inflammatory cytokines and p-IκBα/IκBα was evaluated by western-blot. Assessment of apoptosis was performed by TUNEL assay.MethodsThe skin of normal healthy subjects and severe LHON patients harboring m.11778G > A mutation was taken to prepare immortalized skin fibroblast cell lines (control-iFB and LHON-iFB). LHON-iFB cells were transfected with SOD2 plasmid or negative control plasmid, respectively. In addition, human neuroblastoma SH-SY5Y cells and human primary retinal pigmental epithelium (hRPE) cells were stimulated by H2O2 after gene transfection. The oxygen consumption rate (OCR) was measured with a Seahorse extracellular flux analyzer. The level of ATP production, mitochondrial membrane potential, ROS and malondialdehyde (MDA) were measured separately with the corresponding assay kits. The expression level of SOD2, inflammatory cytokines and p-IκBα/IκBα was evaluated by western-blot. Assessment of apoptosis was performed by TUNEL assay.LHON-iFB exhibited lower OCR, ATP production, mitochondrial membrane potential but higher level of ROS and MDA than control-iFB. Western-blot revealed a significantly increased expression of IL-6 and p-IκBα/IκBα in LHON-iFB. Compared with the negative control, SOD2 overexpression increased OCR, ATP production and elevated mitochondrial membrane potential, but impaired ROS and MDA production. Besides, western-blot demonstrated exogenous SOD2 reduced the protein level of IL-6 and p-IκBα/IκBα. TUNEL assays suggested SOD2 inhibited cells apoptosis. Analogously, in SH-SY5Y and hRPE cells, SOD2 overexpression increased ATP production and mitochondrial membrane potential, but decreased ROS, MDA levels and suppressed apoptosis.ResultsLHON-iFB exhibited lower OCR, ATP production, mitochondrial membrane potential but higher level of ROS and MDA than control-iFB. Western-blot revealed a significantly increased expression of IL-6 and p-IκBα/IκBα in LHON-iFB. Compared with the negative control, SOD2 overexpression increased OCR, ATP production and elevated mitochondrial membrane potential, but impaired ROS and MDA production. Besides, western-blot demonstrated exogenous SOD2 reduced the protein level of IL-6 and p-IκBα/IκBα. TUNEL assays suggested SOD2 inhibited cells apoptosis. Analogously, in SH-SY5Y and hRPE cells, SOD2 overexpression increased ATP production and mitochondrial membrane potential, but decreased ROS, MDA levels and suppressed apoptosis.SOD2 upregulation inhibited cells apoptosis through ameliorating mitochondrial dysfunction and reducing NF-κB associated inflammatory response. This study further support exogenous SOD2 may be a promising therapy for the treatment of LHON.ConclusionSOD2 upregulation inhibited cells apoptosis through ameliorating mitochondrial dysfunction and reducing NF-κB associated inflammatory response. This study further support exogenous SOD2 may be a promising therapy for the treatment of LHON. |
---|---|
AbstractList | BackgroundIn Leber’s hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could ameliorate mtDNA mutation mediated mitochondrial dysfunction in skin fibroblasts of LHON patients and explore the underlying mechanisms.MethodsThe skin of normal healthy subjects and severe LHON patients harboring m.11778G > A mutation was taken to prepare immortalized skin fibroblast cell lines (control-iFB and LHON-iFB). LHON-iFB cells were transfected with SOD2 plasmid or negative control plasmid, respectively. In addition, human neuroblastoma SH-SY5Y cells and human primary retinal pigmental epithelium (hRPE) cells were stimulated by H2O2 after gene transfection. The oxygen consumption rate (OCR) was measured with a Seahorse extracellular flux analyzer. The level of ATP production, mitochondrial membrane potential, ROS and malondialdehyde (MDA) were measured separately with the corresponding assay kits. The expression level of SOD2, inflammatory cytokines and p-IκBα/IκBα was evaluated by western-blot. Assessment of apoptosis was performed by TUNEL assay.ResultsLHON-iFB exhibited lower OCR, ATP production, mitochondrial membrane potential but higher level of ROS and MDA than control-iFB. Western-blot revealed a significantly increased expression of IL-6 and p-IκBα/IκBα in LHON-iFB. Compared with the negative control, SOD2 overexpression increased OCR, ATP production and elevated mitochondrial membrane potential, but impaired ROS and MDA production. Besides, western-blot demonstrated exogenous SOD2 reduced the protein level of IL-6 and p-IκBα/IκBα. TUNEL assays suggested SOD2 inhibited cells apoptosis. Analogously, in SH-SY5Y and hRPE cells, SOD2 overexpression increased ATP production and mitochondrial membrane potential, but decreased ROS, MDA levels and suppressed apoptosis.ConclusionSOD2 upregulation inhibited cells apoptosis through ameliorating mitochondrial dysfunction and reducing NF-κB associated inflammatory response. This study further support exogenous SOD2 may be a promising therapy for the treatment of LHON. In Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could ameliorate mtDNA mutation mediated mitochondrial dysfunction in skin fibroblasts of LHON patients and explore the underlying mechanisms.BackgroundIn Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could ameliorate mtDNA mutation mediated mitochondrial dysfunction in skin fibroblasts of LHON patients and explore the underlying mechanisms.The skin of normal healthy subjects and severe LHON patients harboring m.11778G > A mutation was taken to prepare immortalized skin fibroblast cell lines (control-iFB and LHON-iFB). LHON-iFB cells were transfected with SOD2 plasmid or negative control plasmid, respectively. In addition, human neuroblastoma SH-SY5Y cells and human primary retinal pigmental epithelium (hRPE) cells were stimulated by H2O2 after gene transfection. The oxygen consumption rate (OCR) was measured with a Seahorse extracellular flux analyzer. The level of ATP production, mitochondrial membrane potential, ROS and malondialdehyde (MDA) were measured separately with the corresponding assay kits. The expression level of SOD2, inflammatory cytokines and p-IκBα/IκBα was evaluated by western-blot. Assessment of apoptosis was performed by TUNEL assay.MethodsThe skin of normal healthy subjects and severe LHON patients harboring m.11778G > A mutation was taken to prepare immortalized skin fibroblast cell lines (control-iFB and LHON-iFB). LHON-iFB cells were transfected with SOD2 plasmid or negative control plasmid, respectively. In addition, human neuroblastoma SH-SY5Y cells and human primary retinal pigmental epithelium (hRPE) cells were stimulated by H2O2 after gene transfection. The oxygen consumption rate (OCR) was measured with a Seahorse extracellular flux analyzer. The level of ATP production, mitochondrial membrane potential, ROS and malondialdehyde (MDA) were measured separately with the corresponding assay kits. The expression level of SOD2, inflammatory cytokines and p-IκBα/IκBα was evaluated by western-blot. Assessment of apoptosis was performed by TUNEL assay.LHON-iFB exhibited lower OCR, ATP production, mitochondrial membrane potential but higher level of ROS and MDA than control-iFB. Western-blot revealed a significantly increased expression of IL-6 and p-IκBα/IκBα in LHON-iFB. Compared with the negative control, SOD2 overexpression increased OCR, ATP production and elevated mitochondrial membrane potential, but impaired ROS and MDA production. Besides, western-blot demonstrated exogenous SOD2 reduced the protein level of IL-6 and p-IκBα/IκBα. TUNEL assays suggested SOD2 inhibited cells apoptosis. Analogously, in SH-SY5Y and hRPE cells, SOD2 overexpression increased ATP production and mitochondrial membrane potential, but decreased ROS, MDA levels and suppressed apoptosis.ResultsLHON-iFB exhibited lower OCR, ATP production, mitochondrial membrane potential but higher level of ROS and MDA than control-iFB. Western-blot revealed a significantly increased expression of IL-6 and p-IκBα/IκBα in LHON-iFB. Compared with the negative control, SOD2 overexpression increased OCR, ATP production and elevated mitochondrial membrane potential, but impaired ROS and MDA production. Besides, western-blot demonstrated exogenous SOD2 reduced the protein level of IL-6 and p-IκBα/IκBα. TUNEL assays suggested SOD2 inhibited cells apoptosis. Analogously, in SH-SY5Y and hRPE cells, SOD2 overexpression increased ATP production and mitochondrial membrane potential, but decreased ROS, MDA levels and suppressed apoptosis.SOD2 upregulation inhibited cells apoptosis through ameliorating mitochondrial dysfunction and reducing NF-κB associated inflammatory response. This study further support exogenous SOD2 may be a promising therapy for the treatment of LHON.ConclusionSOD2 upregulation inhibited cells apoptosis through ameliorating mitochondrial dysfunction and reducing NF-κB associated inflammatory response. This study further support exogenous SOD2 may be a promising therapy for the treatment of LHON. |
Author | Li, Ya Zhou, Qingru Yao, Shun Guo, Qingge Li, Lei Lei, Bo Yang, Mingzhu |
AuthorAffiliation | 3 Xinxiang Medical University , Xinxiang , China 2 Henan Eye Hospital, Henan Provincial People’s Hospital, Henan Eye Institute , Zhengzhou , China 1 Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital , Zhengzhou , China |
AuthorAffiliation_xml | – name: 1 Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital , Zhengzhou , China – name: 2 Henan Eye Hospital, Henan Provincial People’s Hospital, Henan Eye Institute , Zhengzhou , China – name: 3 Xinxiang Medical University , Xinxiang , China |
Author_xml | – sequence: 1 givenname: Qingru surname: Zhou fullname: Zhou, Qingru – sequence: 2 givenname: Shun surname: Yao fullname: Yao, Shun – sequence: 3 givenname: Mingzhu surname: Yang fullname: Yang, Mingzhu – sequence: 4 givenname: Qingge surname: Guo fullname: Guo, Qingge – sequence: 5 givenname: Ya surname: Li fullname: Li, Ya – sequence: 6 givenname: Lei surname: Li fullname: Li, Lei – sequence: 7 givenname: Bo surname: Lei fullname: Lei, Bo |
BookMark | eNp9ksluFDEQhlsoiCzwANx85DKDt263L0goYok0EgdA4mZ5KWccuu3BdiPmhngLXo8nwZOJEOHApVwqu776rfrPu5OYInTdU4LXjI3yuY8hljXFlK4lEYyPD7ozMgx0xXv26eSv_LQ7L-UG44GOnD7qTtmAiSCjPOt-vF92kNO34AC5UOal6gKIIj3DFFLWFQqaQ012m6LLQU_I7Ytfoq0hRRQiKp9b8MHkZCZdakHJow0YyL--_yxoCxlcqDrvUdrVYFGEJaedrts9ajFArOVx99DrqcCTu_Oi-_j61YfLt6vNuzdXly83K8s5rSvbGyGw48RZB6Y3PSPegxh6CcQxQYnsWzJYS7xwWnBJwPCR6t4L0WMB7KK7OnJd0jdql8PcZKmkg7otpHytdG4aJ1BWyJFixrxlA9ejM3TEztFRGk5lb3hjvTiydouZwdn2j6yne9D7NzFs1XX6qiRrZMIa4NkdIKcvC5Sq5lAsTJOOkJaiqMBiwHQUh1nk-NTmVEoG_2cMwergA3XrA3XwgTr6oPWIf3ps28JhZ01NmP7T-Rs9-cAA |
CitedBy_id | crossref_primary_10_3390_genes16010108 crossref_primary_10_1167_tvst_12_10_1 crossref_primary_10_3389_fneur_2022_946559 crossref_primary_10_3390_biomedicines12092020 crossref_primary_10_1016_j_yexcr_2024_114075 |
Cites_doi | 10.1242/jcs.099234 10.1167/iovs.17-21546 10.1016/j.cell.2010.02.016 10.1016/j.mito.2020.07.003 10.1016/j.cell.2005.02.001 10.1016/j.ijbiomac.2020.11.149 10.1038/nrneurol.2013.126 10.1097/WCO.0000000000000646 10.1093/brain/aww222 10.1007/s00109-019-01845-1842 10.1016/j.neuroscience.2017.07.053 10.1038/nri2873 10.3389/fnmol.2022.920221 10.1074/jbc.M006476200 10.1016/j.scr.2020.101939 10.3389/fneur.2021.648916 10.1016/j.bbabio.2010.07.005 10.1073/pnas.1217113109 10.1016/j.mito.2016.11.006 10.1042/BJ20091382 10.1021/cr4005296 10.3390/ijms21083027 10.3390/cells7120274 10.1093/hmg/ddaa063 10.1007/s10753-020-01377-1379 10.1093/brain/awq276 10.1016/j.biopha.2005.03.001 10.1016/j.yexcr.2018.01.020 10.1097/WNO.0000000000001375 10.1001/archopht.125.2.268 10.1007/s12031-020-01729-y 10.1080/01616412.2016.1251711 10.3390/ijms22042007 10.1016/j.cbi.2020.109086 10.1016/j.freeradbiomed.2015.05.039 10.1016/j.preteyeres.2010.11.002 10.1016/j.gpb.2022.06.001 10.1016/j.bbabio.2009.02.024 10.1111/j.1749-6632.2009.04901.x 10.1016/j.preteyeres.2006.05.002 10.1089/ars.2011.4066 10.1016/j.freeradbiomed.2011.08.005 10.1073/pnas.0510346103 10.1007/s11306-018-1345-1349 10.1016/j.pharmthera.2016.06.004 10.1007/7651_2021_384 10.1089/ars.2020.8058 10.3390/molecules24081583 10.1016/j.neulet.2017.06.050 10.1186/s40035-022-00308-y |
ContentType | Journal Article |
Copyright | Copyright © 2022 Zhou, Yao, Yang, Guo, Li, Li and Lei. Copyright © 2022 Zhou, Yao, Yang, Guo, Li, Li and Lei. 2022 Zhou, Yao, Yang, Guo, Li, Li and Lei |
Copyright_xml | – notice: Copyright © 2022 Zhou, Yao, Yang, Guo, Li, Li and Lei. – notice: Copyright © 2022 Zhou, Yao, Yang, Guo, Li, Li and Lei. 2022 Zhou, Yao, Yang, Guo, Li, Li and Lei |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fnins.2022.917348 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1662-453X |
ExternalDocumentID | oai_doaj_org_article_c7982033fc364a8db280dd289b4295b4 PMC9398213 10_3389_fnins_2022_917348 |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 29H 2WC 53G 5GY 5VS 8FE 8FH 9T4 AAFWJ AAYXX ABUWG ACGFO ACGFS ACXDI ADRAZ AEGXH AENEX AFKRA AFPKN AIAGR ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI BPHCQ CITATION CS3 DIK DU5 E3Z EBS EJD EMOBN F5P FRP GROUPED_DOAJ GX1 HCIFZ HYE KQ8 LK8 M2P M48 M7P O5R O5S OK1 OVT P2P PGMZT PIMPY PQQKQ PROAC RNS RPM W2D 7X8 5PM |
ID | FETCH-LOGICAL-c442t-c5b770d41dcdeb5b531ffe7659e1d372195e1d6cc1f7da7491eb482a5f77507e3 |
IEDL.DBID | M48 |
ISSN | 1662-453X 1662-4548 |
IngestDate | Wed Aug 27 01:22:32 EDT 2025 Thu Aug 21 13:45:09 EDT 2025 Thu Jul 10 22:58:50 EDT 2025 Tue Jul 01 01:39:42 EDT 2025 Thu Apr 24 22:59:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-c5b770d41dcdeb5b531ffe7659e1d372195e1d6cc1f7da7491eb482a5f77507e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience These authors have contributed equally to this work and share first authorship Reviewed by: Daniela Valenti, Department of Biomedical Sciences, Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (CNR), Italy; Jingfa Zhang, Shanghai General Hospital, China; Haiwei Xu, Army Medical University, China Edited by: Jose Hurst, University Hospital Tübingen, Germany |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnins.2022.917348 |
PMID | 36017189 |
PQID | 2707602874 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c7982033fc364a8db280dd289b4295b4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9398213 proquest_miscellaneous_2707602874 crossref_primary_10_3389_fnins_2022_917348 crossref_citationtrail_10_3389_fnins_2022_917348 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-09 |
PublicationDateYYYYMMDD | 2022-08-09 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-09 day: 09 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in neuroscience |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Singh (B42) 2022; 2549 Sarewicz (B38) 2010; 1797 Yen (B48) 2006; 25 Glass (B12) 2010; 140 Lin (B24) 2012; 109 Zhang (B50) 2010; 16 Islam (B17) 2017; 39 Wu (B45) 2018; 363 Zhou (B51) 2020; 21 Yao (B47) 2022; 15 Jurkute (B20) 2019; 32 Jankauskaite (B18) 2017; 32 Carelli (B3) 2009; 1787 Dranka (B8) 2011; 51 Kausar (B21) 2018; 7 Singh (B41) 2019; 24 Rovcanin (B37) 2021; 71 Jin (B19) 2022 Brown (B2) 2000; 275 Sheng (B40) 2014; 114 Harvey (B13) 2022; 42 Qi (B34) 2007; 125 Rosa (B36) 2021; 168 Fan (B9) 2020; 324 Giordano (B11) 2011; 134 Morvan (B29) 2018; 14 DiMauro (B7) 2013; 9 Nguyen (B30) 2020; 98 Lopez Sanchez (B26) 2016; 165 Miyoshi (B28) 2006; 103 Chen (B6) 2010; 10 Lopez Sanchez (B27) 2020; 54 Liskova (B25) 2021; 22 Lei (B23) 2017; 360 Chao de la Barca (B5) 2016; 139 Hayashi (B14) 2015; 88 Olesen (B31) 2022; 11 Balaban (B1) 2005; 120 Cerella (B4) 2009; 1171 Hirst (B16) 2009; 425 Peron (B32) 2021; 12 Yang (B46) 2020; 29 Hernandez-Saavedra (B15) 2005; 59 Peron (B33) 2020; 48 Kwon (B22) 2012; 16 Qiu (B35) 2021; 44 Tait (B43) 2012; 125 Yu-Wai-Man (B49) 2011; 30 van Horssen (B44) 2019; 710 Schofield (B39) 2021; 34 Fu (B10) 2017; 58 |
References_xml | – volume: 125 start-page: 807 year: 2012 ident: B43 article-title: Mitochondria and cell signalling. publication-title: J. Cell Sci. doi: 10.1242/jcs.099234 – volume: 58 start-page: 3018 year: 2017 ident: B10 article-title: Overexpression of angiotensin-converting enzyme 2 ameliorates amyloid beta-induced inflammatory response in human primary retinal pigment epithelium. publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.17-21546 – volume: 140 start-page: 918 year: 2010 ident: B12 article-title: Mechanisms underlying inflammation in neurodegeneration. publication-title: Cell doi: 10.1016/j.cell.2010.02.016 – volume: 54 start-page: 113 year: 2020 ident: B27 article-title: OXPHOS bioenergetic compensation does not explain disease penetrance in Leber hereditary optic neuropathy. publication-title: Mitochondrion doi: 10.1016/j.mito.2020.07.003 – volume: 120 start-page: 483 year: 2005 ident: B1 article-title: Mitochondria, oxidants, and aging. publication-title: Cell doi: 10.1016/j.cell.2005.02.001 – volume: 168 start-page: 846 year: 2021 ident: B36 article-title: Strategies to expand the therapeutic potential of superoxide dismutase by exploiting delivery approaches. publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2020.11.149 – volume: 9 start-page: 429 year: 2013 ident: B7 article-title: The clinical maze of mitochondrial neurology. publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2013.126 – volume: 32 start-page: 99 year: 2019 ident: B20 article-title: Treatment strategies for Leber hereditary optic neuropathy. publication-title: Curr. Opin. Neurol. doi: 10.1097/WCO.0000000000000646 – volume: 139 start-page: 2864 year: 2016 ident: B5 article-title: The metabolomic signature of Leber’s hereditary optic neuropathy reveals endoplasmic reticulum stress. publication-title: Brain doi: 10.1093/brain/aww222 – volume: 98 start-page: 59 year: 2020 ident: B30 article-title: Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases. publication-title: J. Mol. Med. doi: 10.1007/s00109-019-01845-1842 – volume: 360 start-page: 48 year: 2017 ident: B23 article-title: Amelioration of amyloid beta-induced retinal inflammatory responses by a LXR agonist TO901317 is associated with inhibition of the NF-kappaB signaling and NLRP3 inflammasome. publication-title: Neuroscience doi: 10.1016/j.neuroscience.2017.07.053 – volume: 10 start-page: 826 year: 2010 ident: B6 article-title: Sterile inflammation: sensing and reacting to damage. publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2873 – volume: 15 year: 2022 ident: B47 article-title: Multi-mtDNA variants may be a factor contributing to mitochondrial function variety in the skin-derived fibroblasts of leber’s hereditary optic neuropathy patients. publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2022.920221 – volume: 275 start-page: 39831 year: 2000 ident: B2 article-title: Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber’s hereditary optic neuropathy mitochondrial DNA mutation. publication-title: J. Biol. Chem. doi: 10.1074/jbc.M006476200 – volume: 48 year: 2020 ident: B33 article-title: Generation of a human iPSC line, FINCBi001-A, carrying a homoplasmic m.G3460A mutation in MT-ND1 associated with Leber’s Hereditary optic Neuropathy (LHON). publication-title: Stem Cell Res. doi: 10.1016/j.scr.2020.101939 – volume: 12 year: 2021 ident: B32 article-title: Exploiting hiPSCs in leber’s hereditary optic neuropathy (LHON): present achievements and future perspectives. publication-title: Front. Neurol. doi: 10.3389/fneur.2021.648916 – volume: 1797 start-page: 1820 year: 2010 ident: B38 article-title: Discrimination between two possible reaction sequences that create potential risk of generation of deleterious radicals by cytochrome bc(1). Implications for the mechanism of superoxide production. publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbabio.2010.07.005 – volume: 109 start-page: 20065 year: 2012 ident: B24 article-title: Mouse mtDNA mutant model of Leber hereditary optic neuropathy. publication-title: Proc. Natl. Acad. Sci. U S A. doi: 10.1073/pnas.1217113109 – volume: 32 start-page: 19 year: 2017 ident: B18 article-title: Investigating Leber’s hereditary optic neuropathy: cell models and future perspectives. publication-title: Mitochondrion doi: 10.1016/j.mito.2016.11.006 – volume: 425 start-page: 327 year: 2009 ident: B16 article-title: Towards the molecular mechanism of respiratory complex I. publication-title: Biochem. J. doi: 10.1042/BJ20091382 – volume: 114 start-page: 3854 year: 2014 ident: B40 article-title: Superoxide dismutases and superoxide reductases. publication-title: Chem. Rev. doi: 10.1021/cr4005296 – volume: 21 year: 2020 ident: B51 article-title: Increased Protein S-Glutathionylation in Leber’s Hereditary Optic Neuropathy (LHON). publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21083027 – volume: 7 year: 2018 ident: B21 article-title: The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. publication-title: Cells doi: 10.3390/cells7120274 – volume: 29 start-page: 1454 year: 2020 ident: B46 article-title: Mitochondrial transport mediates survival of retinal ganglion cells in affected LHON patients. publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddaa063 – volume: 44 start-page: 780 year: 2021 ident: B35 article-title: The protective effects of VVN001 on LPS-Induced inflammatory responses in human RPE cells and in a mouse model of EIU. publication-title: Inflammation doi: 10.1007/s10753-020-01377-1379 – volume: 134 start-page: 220 year: 2011 ident: B11 article-title: Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. publication-title: Brain doi: 10.1093/brain/awq276 – volume: 59 start-page: 204 year: 2005 ident: B15 article-title: Anti-inflammatory properties of a chimeric recombinant superoxide dismutase: SOD2/3. publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2005.03.001 – volume: 363 start-page: 299 year: 2018 ident: B45 article-title: Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber’s hereditary optic neuropathy. publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2018.01.020 – volume: 42 start-page: 35 year: 2022 ident: B13 article-title: Induced pluripotent stem cells for inherited optic neuropathies-disease modeling and therapeutic development. publication-title: J. Neuroophthalmol. doi: 10.1097/WNO.0000000000001375 – volume: 125 start-page: 268 year: 2007 ident: B34 article-title: Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. publication-title: Arch. Ophthalmol. doi: 10.1001/archopht.125.2.268 – volume: 71 start-page: 1070 year: 2021 ident: B37 article-title: Oxidative stress profile in genetically confirmed cases of leber’s hereditary optic neuropathy. publication-title: J. Mol. Neurosci. doi: 10.1007/s12031-020-01729-y – volume: 39 start-page: 73 year: 2017 ident: B17 article-title: Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. publication-title: Neurol. Res. doi: 10.1080/01616412.2016.1251711 – volume: 22 year: 2021 ident: B25 article-title: Mitochondriopathies as a clue to systemic disorders-analytical tools and mitigating measures in context of predictive. preventive, and personalized (3p) medicine. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22042007 – volume: 324 year: 2020 ident: B9 article-title: Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation. publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2020.109086 – volume: 88 start-page: 10 year: 2015 ident: B14 article-title: Oxidative stress in inherited mitochondrial diseases. publication-title: Free Radic Biol. Med. doi: 10.1016/j.freeradbiomed.2015.05.039 – volume: 30 start-page: 81 year: 2011 ident: B49 article-title: Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2010.11.002 – year: 2022 ident: B19 article-title: Identification of age-associated proteins and functional alterations in human retinal pigment epithelium. publication-title: Genom. Proteom. Bioinform. doi: 10.1016/j.gpb.2022.06.001 – volume: 1787 start-page: 518 year: 2009 ident: B3 article-title: Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbabio.2009.02.024 – volume: 1171 start-page: 559 year: 2009 ident: B4 article-title: Multiple mechanisms for hydrogen peroxide-induced apoptosis. publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.2009.04901.x – volume: 16 start-page: 2867 year: 2010 ident: B50 article-title: Immunopanning purification and long-term culture of human retinal ganglion cells. publication-title: Mol. Vis. – volume: 25 start-page: 381 year: 2006 ident: B48 article-title: Leber’s hereditary optic neuropathy: a multifactorial disease. publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2006.05.002 – volume: 16 start-page: 297 year: 2012 ident: B22 article-title: Superoxide dismutase 3 suppresses hyaluronic acid fragments mediated skin inflammation by inhibition of toll-like receptor 4 signaling pathway: superoxide dismutase 3 inhibits reactive oxygen species-induced trafficking of toll-like receptor 4 to lipid rafts. publication-title: Antioxid. Redox. Signal. doi: 10.1089/ars.2011.4066 – volume: 51 start-page: 1621 year: 2011 ident: B8 article-title: Assessing bioenergetic function in response to oxidative stress by metabolic profiling. publication-title: Free Radic Biol. Med. doi: 10.1016/j.freeradbiomed.2011.08.005 – volume: 103 start-page: 1727 year: 2006 ident: B28 article-title: Age-dependent cell death and the role of ATP in hydrogen peroxide-induced apoptosis and necrosis. publication-title: Proc. Natl. Acad. Sci. U S A. doi: 10.1073/pnas.0510346103 – volume: 14 year: 2018 ident: B29 article-title: NMR metabolomics of fibroblasts with inherited mitochondrial complex I mutation reveals treatment-reversible lipid and amino acid metabolism alterations. publication-title: Metabolomics doi: 10.1007/s11306-018-1345-1349 – volume: 165 start-page: 132 year: 2016 ident: B26 article-title: Emerging mitochondrial therapeutic targets in optic neuropathies. publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2016.06.004 – volume: 2549 start-page: 219 year: 2022 ident: B42 article-title: Creating cell model 2.0 using patient samples carrying a pathogenic mitochondrial DNA mutation: iPSC approach for LHON. publication-title: Methods Mol. Biol. doi: 10.1007/7651_2021_384 – volume: 34 start-page: 517 year: 2021 ident: B39 article-title: Mitochondrial reactive oxygen species and mitophagy: a complex and nuanced relationship. publication-title: Antioxid. Redox. Signal. doi: 10.1089/ars.2020.8058 – volume: 24 year: 2019 ident: B41 article-title: Oxidative stress: a key modulator in neurodegenerative diseases. publication-title: Molecules doi: 10.3390/molecules24081583 – volume: 710 year: 2019 ident: B44 article-title: Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders? publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2017.06.050 – volume: 11 year: 2022 ident: B31 article-title: The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. publication-title: Transl. Neurodegener. doi: 10.1186/s40035-022-00308-y |
SSID | ssj0062842 |
Score | 2.3676512 |
Snippet | In Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial... BackgroundIn Leber’s hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells.... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 917348 |
SubjectTerms | LHON mitochondrial dysfunction Neuroscience oxidative stress retinal ganglion cell SOD2 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wqoFQsFGQkxKFS6Ca24_hYEFWFWi6lUm-Rf9WIrlNtslL3VvUteD2ehBknW20ucOESRbETO57x_Njjbwj5MIcC7pTMSm1sxrXKs4obk0mFi27GWJMOCp9_L08v-bcrcbWV6gtjwgZ44GHgjqxUoKQYC5aVXFfOFNXcOXATDEhSYRISKOi8jTM1yOAShG4x7GGCC6aOQmwiYnMXxSdwTxgm-9nSQgmsf2JhTuMjtxTOyTOyO1qK9Hjo4XPyxMcXZO84gpe8WNOPNMVupkXxPfJwsULA77vGeeqaboGB1p4WVC_8DZ7BB3uSLmDugqyLDlmOunWHKg3JQptIu59wCeA6twbM6b6jbaBnMMDL3_e_OnqNCT2bXi_XtAURY2lCwcRkxms6ArN2L8nlydcfX06zMbtCZjkv-swKI-Xc8dxZ540wMBlD8LIUyueOgWOoBNyU1uZBOi25yr3hVaFFkGBlSM_2yU5so39FqBOVzcsqMAHfc2DyBSdNgdliwKDzms3IfDPatR2hxzEDxk0NLggSqE4EqpFA9UCgGTl8fOV2wN34W-XPSMLHigiZnR4AI9UjI9X_YqQZeb9hgBqmGO6b6OjbFbQkcfsSEwPMiJxwxqTFaUlsrhNYt2LQbM5e_48uviFP8a9T_KE6IDv9cuXfgk3Um3eJ_f8AQBwRIg priority: 102 providerName: Directory of Open Access Journals |
Title | Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber’s hereditary optic neuropathy patients |
URI | https://www.proquest.com/docview/2707602874 https://pubmed.ncbi.nlm.nih.gov/PMC9398213 https://doaj.org/article/c7982033fc364a8db280dd289b4295b4 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9RAFB1qBemLqFVcq2UE8UFI3WQmmcyDSBVrEeuLLuxbyHy1wd2JTbLQvIn_wr_nL_He2ezSQPHBl7BsPobMnZt77tyZcwh5MYUT3EgRZaXSES9lHOVcqUhInHRTSquwUfjsS3Y645_m6XyHbOSthg5sb0ztUE9q1iyOri77t-DwbzDjhHj72vnKI_N2khxB8sF4fovchsAk0E_P-LaokMGXOBQ_M9woBEh9XeS8-RF75A7LkEsG9d-vRaxA7D9Co-O1lNeC08k9cndAlfR4PQzukx3rH5D9Yw8Z9bKnL2lY5xkm0PfJr68rJAe_qoylpmqXuCjb0oSWS7vA_fqAPekS_By6xhscntT0LYY_NCGtPG2_w8FBml0rgN5dS2tHP4Mxmj8_f7f0AsU_q65selrD50jTwJiJwsc9HUhc24dkdvLh2_vTaFBiiDTnSRfpVAkxNTw22liVKnBc56zIUmljwyCJlCn8yLSOnTCl4DK2iudJmToBiERY9ojs-trbx4SaNNdxljuWwvMMwENnhEpQWQbAny3ZhEw3vV3ogaYc1TIWBaQraKsi2KpAWxVrW03Iq-0tP9YcHf-6-B2acHsh0muHP-rmvBi8tdBCAjJizGmW8TI3KsmnxkBuqiB8p4pPyPPNACjAHbHGUnpbr6AlgaVOFBGYEDEaGaMWx2d8dRGIvSWDZmP25L_vPCB7-KphgaJ8Sna7ZmWfAWjq1GGYbIDjx3l8GNziL8aMHkM |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Superoxide+dismutase+2+ameliorates+mitochondrial+dysfunction+in+skin+fibroblasts+of+Leber%E2%80%99s+hereditary+optic+neuropathy+patients&rft.jtitle=Frontiers+in+neuroscience&rft.au=Zhou%2C+Qingru&rft.au=Yao%2C+Shun&rft.au=Yang%2C+Mingzhu&rft.au=Guo%2C+Qingge&rft.date=2022-08-09&rft.pub=Frontiers+Media+S.A&rft.issn=1662-4548&rft.eissn=1662-453X&rft.volume=16&rft_id=info:doi/10.3389%2Ffnins.2022.917348&rft_id=info%3Apmid%2F36017189&rft.externalDocID=PMC9398213 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-453X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-453X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-453X&client=summon |